Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BW-ACCORD
2024-518890-33-00Phase 4Authorised
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of prasugrel and clopidogrel in Chronic Coronary Syndrome (CCS) and coronary arteriosclerosis (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Platelet reactivity (PRU). Planned start Nov 2024; status: authorised.
02
Drugs
prasugrelclopidogrel
03
Conditions
Chronic Coronary Syndrome (CCS)coronary arteriosclerosis
Beyond the preview
Go deeper on 2024-518890-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518890-33-00.